Skip to content

ClearPoint Neuro CLPT Change in Lease Liabilities

Change in Lease Liabilities at other companies

Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$513K-14.0%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$2.77M+17.1%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
-$5M-4.3%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$211K-14.7%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
-$5.29M+19.2%

Other financials

Income statement

See full
Revenue$12.1M+42.9%
Gross profit$7.8M+51.1%
Operating income-$8.5M-37.6%
Net income-$9.6M-58.5%
EPS (diluted)-$0.32-45.5%

Balance sheet

See full
Cash & equivalents$36.5M+195%
Total debt$63.6M+1,750%
Total equity$18.8M-5.7%
Total assets$93.4M+211%

Cash flow

See full
Operating cash flow-$8.0M-29.1%
CapEx$645.0K+252%
Free cash flow-$8.6M-35.5%

Valuation

See full
Market cap$538.61M+69.2%
Enterprise value$565.68M+82.9%
P/S13.3×+3.4×

Profitability

See full
Gross margin62.3%+1.1pp
Operating margin-65.2%-1.9pp
Net margin-71.6%+8.8pp
FCF margin-65.7%+269pp

Returns & leverage

See full
Return on equity-149.7%+4,074pp
Debt / equity3.4×+3.2×
Current ratio5.8×+2.3×

Where this comes from

Reported directly by ClearPoint Neuro in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: ClearPoint Neuro’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about ClearPoint Neuro's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ClearPoint Neuro's change in lease liabilities?
ClearPoint Neuro (CLPT) reported change in lease liabilities of -$391K in Q1 2026.
How has ClearPoint Neuro's change in lease liabilities changed year-over-year?
ClearPoint Neuro's change in lease liabilities decreased by 67.1% year-over-year, from -$234K to -$391K.
What is the long-term trend for ClearPoint Neuro's change in lease liabilities?
Over 3 years (2022 to 2025), ClearPoint Neuro's change in lease liabilities has grown at a 23.2% compound annual growth rate (CAGR), from -$541K to -$1.01M.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.